Ongoing clinical trials are using CRISPR Cas9 to genetically

Last updated: 2/8/2023

Ongoing clinical trials are using CRISPR Cas9 to genetically modify the blood cells of people with sickle cell anemia The aim is to help relieve the intense pain and health complications associated with this blood condition This is an example of O Somatic gene editing IVF Germline gene editing Heritable genome editing